Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Synthesis
Chemistry In Pictures
Chemistry in Pictures: See the vial for the trees
by Manny Morone
August 7, 2019
After synthesizing this indenothiazepinone derivative, Mohamed A. Seleem noticed the branching, tree-like design it made on the walls of this vial. Seleem is a PhD student in the lab of Martin Conda-Sheridan at the University of Nebraska Medical Center studying the antimicrobial activity of this group of compounds against microorganisms like the ones that cause malaria and chlamydia. The structure of the protein that these researchers think they are targeting, ClpX, still has not been solved, so they are modifying the indenothiazepinone molecules and testing their activity against ClpX to see if they can tease out how the protein works and how it’s structured.
Submitted by Mohamed A. Seleem
Do science. Take pictures. Win money. Enter our photo contest here.
Related C&EN Content:
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter